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β-catenin/Tcf and NF-κB signaling pathways play an important role in biological functions and crosstalk between these pathways has been
reported. We found that the modulation of NF-κB activity showed a direct correlation with β-catein/Tcf pathway in human adipose tissue
(hASCs) and bone marrow (hBMSCs)-derived mesenchymal stem cells. Expression of lzts2, which inhibits nuclear translocation of β-catenin and
its transactivation activity, was regulated by NF-κB activity. Downregulation of lzts2 by RNA interference increased the nuclear translocation of
β-catenin and NF-κB activity in hASCs. NF-κB activation by the downregulation of lzts2 was accompanied by the increase of β-TrCP1
expression and the decrease of IκB level. Downregulation of lzts2 increased the proliferation of hASCs and hBMSC, and blocked the NF-κB
inhibitor-induced inhibitory effect on their proliferation and Tcf promoter activation. These findings provide the first evidence that the reciprocal
crosstalk between β-catenin/Tcf pathway and NF-κB signaling in hMSCs is mediated through the regulation of lzts2 expression.
© 2007 Elsevier B.V. All rights reserved.Keywords: hASCs; β-Catenin/Tcf; NF-κB; lzts2; β-TrCP1. Introduction
Postnatal human bone marrow stromal cells (hBMSCs) or
mesenchymal stem cells (hMSCs) have the capacity to
regenerate a hematopoietic-supportive bone marrow organ and
associated bone trabecular, when transplanted into immuno-
compromised mice [1,2]. Recent studies have also reported that
MSCs are more plastic than first realized, by virtue of their
ability to develop into diverse cell lineages such as myelosup-
portive stroma, osteoblasts, chondrocytes, adipocytes, myo-
blasts, hepatocytes, cardiomyocytes, and neural cells [3–5].
These developments have prompted investigations into the
possible use of ex vivo expanded MSC populations for a wide
range of tissue engineering and gene therapy applications [6].⁎ Corresponding author. Department of Physiology, School of Medicine,
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doi:10.1016/j.bbamcr.2007.08.005Therefore, it is important to have a thorough understanding of
the specific signals dictating cellular behavior and the specific
cues that induce or inhibit differentiation, and/or promote the
maintenance of these cells. Human adipose tissues have been
known to possess multipotential adult stem cells, capable of
differentiating into a variety of cell types such as osteoblasts,
chondrocytes, adipocytes, muscle cells, and neural cells [5,7].
We and other investigators have shown that culture expanded
human adipose tissue-derived cells have a characteristic of
MSCs and show similar biologic properties as hBMSCs in vitro
and in vivo [8–12], although freshly isolated cells from human
adipose tissues contain heterogenous cells and show different
surface marker expression with hBMSCs [13–17].
The Wnt family of secretory glycoproteins plays an
important role in embryonic development, the induction of
cell polarity, and in the determination of cell fate. Deregulation
of Wnt signaling disrupts axis formation in embryos [18–20]
and is associated with multiple human malignancies [21].
Wnt signaling also plays an important role in the proliferation
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NF-κB signaling pathway is another important signal transduc-
tion pathway that plays a critical role in activating the ex-
pression of genes involved in the immune and inflammatory
response and in regulating cellular apoptosis [24–27]. NF-κB is
an important mediator for the production of cytokine and
chemokines in hMSCs [28].
Deng and colleagues [29] first suggested that β-catenin
interacted with NF-κB and inhibited its activity in human colon
and breast cancer cells. They found that β-catenin could physi-
cally complex with NF-κB, resulting in a reduction of NF-κB
DNA binding, transactivation activity, and target gene expres-
sion. Subsequently, several studies have demonstrated that the
activation of the β-catenin/Tcf pathway negatively regulates the
NF-κB pathway in colon and breast cancer cells [30] and in
response to bacterial stimulation in intestinal epithelial cells
[31]. On the other hand, stimulation of the Wnt cascade through
the upregulation of eitherWnt or degradation-resistantβ-catenin
significantly enhances both baseline and TNF-α-induced NF-κB
activity, which is mediated through the E3 ligase TrCP1, in
vascular smooth muscles [32]. These findings highlight the
complex interactions between the β-catenin/Tcf and NF-κB
signaling pathways and further emphasize the importance of
characterizing their interactive role in biological functions.
However, crosstalk between these two pathways has not been
examined in hMSCs. The aim of this study was to determine theFig. 1. Effect of NF-κB inhibitors on NF-κB and β-catenin/Tcf signaling pathways
constructs and β-Gal vector. (B and C) hASCs and hBMSCs (B) and cancer cell
constructs and β-Gal vector. Transfected cells were treated without or with SN50 (50
activity. Data represent mean±S.E.M. of four different experiments. ⁎pb0.05 compeffect of the modulation of NF-κB activity on β-catenin/Tcf
signaling and the molecular mechanisms underlying this activity
in hMSCs.
2. Materials and methods
2.1. Cell culture
Human adipose tissue-derived mesenchymal stem cells (hASCs) and human
bone marrow stromal cells (hBMSCs) were cultured as described by Lee et al.
[9]. All protocols involving human subjects were approved by the Institutional
ReviewBoard of Pusan National University.We obtained the adipose tissues of 3
different patients with informed consent who performed abdominoplasty (41-
year-old male patient, 52-year-old female patient and 58-year-old female
patient). To isolate hASCs, adipose tissue samples were washed with phosphate-
buffered saline (PBS) and digested at 37 °C for 30 min with 0.075% type I
collagenase. Enzyme activity was neutralized with α-modified Eagle's medium
(α-MEM) containing 10% fetal bovine serum (FBS). The samples were
centrifuged at 1200×g for 10 min and the pellet was incubated overnight at 37 °C
under 5% CO2 in a control medium (α-MEM, 10% FBS, 100 U/ml of penicillin
and 100 μg/ml of streptomycin). Following incubation, the tissue culture plates
were washed to remove any residual nonadherent cells and then maintained at
37 °C under 5% CO2 in the control medium. Bone marrow samples were
obtained from the proximal femur of two patients (52-year-old male patient and
54-year-old female patient) who performed total hip replacement surgery.
Mononuclear cells from bone marrow were separated by centrifugation in
a Ficoll-Hypaque gradient (density=1.077 g/cm3; Sigma, USA), suspended inα-
MEM containing 10% FBS, 100 U/ml of penicillin and 100 μg/ml of
streptomycin and seeded at a concentration of 1×106 cells/cm2. Cultures were
maintained at 37 °C in a humidified atmosphere containing 5% CO2. When the
monolayer of adherent cells reached 70% confluence, they were trypsinizedin hASCs and hBMSCs. (A) hASCs were cotransfected with NF-κB reporter
lines (C) were cotransfected with either TOPFLASH or FOPFLASH reporter
and 100 μg/ml) for 48 h. Luciferase activity was normalized by β-galactosidase
ared with data in the absence of SN50.
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10%FBS, and subcultured at a concentration of 2000 cells/cm2.We used 3rd–5th
passage of cells isolated from two different donors at each experimental setting.
2.2. Reporter gene assay
All transient transfections were performed with Lipofectamine Plus Reagent
(Invitrogen). The transient transfections were performed using pTOP-flash
(containing triple Tcf/Lef1 binding sites, the basic thymidine kinase promoter
and firefly luciferase reporter gene), pFOP-flash (containing mutated Tcf/Lef1
binding sites), pNF-κB-Luc, pCMV-β-Gal plasmid (Clontech Laboratories, Inc.,
CA) and the p65 plasmid (pCMVp65 NF-κB). pTop-flash, but not pFop-flash, is
responsive to co-activation of TCF/LEF by β-catenin. The cells were harvested
48 h after transfection in 0.25 M Tris, 2 mM DTT, 2 Mm 1,2-diaminocyclohex-
ane-N,N,N′,N′-tetraacetic acid, 10% glycerol and 1% Triton X-100 buffer (lysis
buffer), and subsequently assayed for luciferase activity (Luciferase Assay
System, Promega corporation, Madison, WI). The β-galactosidase activity was
determined using the β-galactosidase Enzyme Assay System (Promega
corporation, Madison, WI). Luciferase activity was normalized by β-
galactosidase activity. Transfections were conducted in duplicate, and all
experiments were repeated four times.
2.3. Nuclear and cytosolic fractionation and Western blot analysis
The cultured cells were trypsinized and washed with cold PBS, and the cell
pellets were resuspended in ice-cold lysis buffer (210 mM mannitol, 70 mM
sucrose, 5 mM Tris, pH 7.5, 1 mM EDTA) supplemented with protease
inhibitors. After being incubated on ice for 15 min, the cells were homogenized
(15 strokes). The nuclei were separated by centrifugation (10 min, 4 °C), and the
supernatant containing the cytosolic fraction was boiled in sample buffer. TheFig. 2. Effect ofNF-κB activity onβ-catenin/Tcf pathway in hASCs. (A) hASCswere co
β-Gal vector, and incubated with either mutant or NF-κB decoy for 48 h. To determine t
pCMVempty vector in combination with reporter constructs. Luciferase activity was de
represent mean±S.E.M. of four different experiments. ⁎pb0.05 compared with the data
translocation analysis of NF-κB andβ-catenin in hASCs. hASCs were treated without or
immunoblotted with antibodies against β-catenin, p65 and β-actin. One representativepellet containing the nuclei was washed with PBS and then resuspended in RIPA
buffer (Santa Cruz Biotechnology, Inc., CA) for 5 min on ice. The pellet was then
centrifuged again, and the supernatant (nuclear fraction) was boiled in sample
buffer. Nuclear and cytosolic proteins were loaded on 10% SDS polyacrylamide
gels, electrotransferred to nitrocellulose membranes (Hybond-ECL, Amersham
Pharmacia Biotech, Piscataway, NJ) and then probedwithmonoclonal antibodies
(β-catenin, and actin; BD Biosciences Clontech, CA, NF-κBp65: Santa Cruz
Biotechnology, Inc., CA). Immunoreactive bands were detected using anti-
mouse and anti-rabbit peroxidase-conjugated secondary antibodies (Amersham
Pharmacia Biotech, Piscataway, NJ) and visualized by enhanced chemilumines-
cence (ECL detection kit, Amersham Pharmacia Biotech, Piscataway, NJ).
2.4. Decoy oligodeoxynucleotide (ODN) technique
Sequence-specific inhibition of NF-κB can be accomplished with synthetic
double-stranded (ds) phosphorothioate oligonucleotides containing a NF-κB
consensus sequence, which acts in vivo as a “decoy” cis element to bind trans-
cription factors and block the activation of cognate genes. The NF-κB decoy and
mutated controls used were double-stranded phosphorothioate oligonucleotides.
Their sequences were as follows: NF-κB consensus sequence (5′-AGTT-
GAGGGGACTTTCCCAGGC-3′), mutated control (5′-AGTTGAGGC-
GACTTTCCCAGGC-3′). Double-stranded (ds) ODNs were prepared from
complementary single-stranded phosphorothioate-bonded oligonucleotides by
melting at 95 °C for 5 min, followed by a 3- to 4-h reconstitution period at RT.
The cells were preincubated with 10 μM ds ODN for 48 and 72 h.
2.5. Small interfering RNA transfection
Small interfering RNA (siRNA) duplex oligo (on-TARGET plus SMART
pool, Dharmacon, Inc., CO) targeting lzts2 (leucine zipper, putative tumortransfected with either NF-κBor Tcf reporter constructs vector in combination with
he effect of p65 overexpression, hASCs were cotransfected with either pCMV65 or
termined at 48 h after transfection and normalized byβ-galactosidase activity. Data
of mutant decoy or pCMV vector-transfected cells. (B) Effect of SN50 on nuclear
with SN50 (100 μg/ml) for 48 h and then total, cytosolic and nuclear proteins were
experiment from three independent experiments was shown.
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siCONTROL, Dharmacon, Inc., CO) as a negative control was transfected
using DharmaFECT Transfection Reagent.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
analysis
The total cellular RNA was isolated from the cells and reverse transcribed
using the conventional protocols. PCR amplification was performed using the
following primer sets: GAPDH 5′-TCCATGACAACTTTGGTATCG-3′, 5′-
TGTAGCCAAATTCGTTGTCA-3′, lzts2 5′-CTGTGTCCTGGAAGGAAAG-
C-3′, 5′-CTCCCACTTGGTCTCCTCAA-3′. All of the primer sequences were
determined using established GenBank sequences. The designed primers were
used to amplify the duplicate PCR reactions, and GAPDH was used as a
control.
2.7. Real-time polymerase chain reaction
Total RNAwas extracted and the mRNA expression levels of actin, lzts2 and
β-TrCP1 were evaluated by real-time RT-PCR. The primer sequences used in the
experiment were as follows: β-actin, 5′-CTGGTGCCT GGG GCG-3′, 5′-
AGCCTCGCCTTTGCCGA-3′; lzts2, 5′-AGAAGCGGCAATTGCAGGAC-3′,
5′-CTCGCCTGATTTCTGGCACA-3′; β-TrCP1, 5′-TAGCAGAGCAGTC-
CAACCCAGA-3′, 5′-CTGTTGGTGAACAACTGTGTGGAG-3′, cyclin D1
5′-TGATGCTGGGCACTTCATCTG-3′, 5′-TCCAATCATCCCGAATGA-
GAGTC-3′. Real-time quantitation was based on the LightCycler assay, using
a fluorogenic SYBR Green I reaction mixture for PCR with the LightCycler
Instrument (Roche, Mannheim, Germany). The amplification program consisted
of one cycle of 95 °C with a 60-s hold (“hot start”), followed by 45 cycles ofFig. 3. Effect of NF-κb signal on lzts2 expression in hASCs. hASCs were
transfected with pCMVand pCMV65 plasmid or treated with mutant decoy, NF-κB
decoy and SN50 (100 μg/ml). Total RNAs were isolated at 48 h after transfection or
treatment, and lzts2mRNA level in hASCswas determined byRT-PCR (A) and real-
time PCR (B). Data represent mean±S.E.M. of three different experiments.
⁎pb0.05 compared with the data of control cells.95 °C with a 0-s hold, specified annealing temperature with a 5-s hold, 72 °C
with 12-s hold, and specified acquisition temperature with a 2-s hold. All
experiments were conducted three times, and negative and positive controls
were included in all experiments. β-Actin mRNA was amplified as an internal
control. LightCycler software version 3.3 (Roche Diagnostics) was used to
analyze PCR kinetics and calculate quantitative data. A standard curve
generated in a separate run was loaded into runs of each samples (without
standard curves). Each run included one sample of known concentration and in
the range covered by the standard curve, thus allowing the estimation of exact
copy numbers by the second derivative maximum method. For each sample,
copy numbers of target gene mRNAwere divided by those of β-actin mRNA to
normalize for target gene mRNA expression and thus avoid sample-to-sample
differences in RNA quantity.
2.8. Proliferation assay
To determine the proliferation rate, hASCs were plated at a density of 2000/
cm2 in a 6-well plate. After 48 and 72 h, the cells were trypsinized and stained
with 0.4% trypan blue (Sigma, St. Louis, MO, USA). The total cell number was
measured with a hemocytometer. This experiment was repeated four times. Cell
proliferation was evaluated by a MTT assay. After washing cells, culture
medium containing 0.5 mg/ml of MTT was added to each well. Cells were
incubated for 2 h at 37 °C, the supernatant was removed and the formazan
crystals formed in viable cells were solubilized with 110 μl of dimethyl
sulfoxide. A 110 μl aliquot of each sample was then transferred to 96-well plates
and the absorbance of each well was measured at 550 nm with ELISA Reader
(Bio-Tek instrument, Winooski, VT, USA).
2.9. Cell cycle analysis
About 105 to 106 cells were washed in phosphate-buffered saline and fixed
with cold 70% ethanol containing 0.5% Tween 20 at 4 °C. Cells were washed
and resuspended in 1.0 ml of propidium iodide solution containing RNase A
(10 mg/ml) and propidium iodide (50 μg/ml). Cells were incubated either for
15 min at 37 °C or for 30 min at room temperature and then subjected to flow
cytometry (FACsort Becton Dickinson, CA).
2.10. Statistical analysis
Comparisons between 2 groups were analyzed via a Student's t test ( pb0.05),
and comparisons between 3 groups were analyzed by ANOVA with a Student–
Newman–Keuls post hoc test ( pb0.05). Data are presented as mean±S.E.3. Results
We first sought to determine the effect of inhibition of NF-κB
signaling by treatment with SN50, an inhibitor of NF-κB nuclear
translocation, on β-catenin/Tcf signaling in hASCs. β-Catenin/
Tcf and NF-κB signaling were assayed by transfection of
luciferase constructs containing the Tcf promoter or NF-κB
promoter in hASCs, respectively. One day after the transfection,
cells were treated with SN50 for 2 days. The treatment of hASCs
with SN50 (50 or 100 μg/ml) inhibited the luciferase activity of
the NF-κB promoter-luciferase construct and that of the Top-
Flash construct (Fig. 1A, B), whereas SN50 did not affect the
luciferase activity of the Fop-Flash construct. To test whether the
effect is specific to MSCs derived from human adipose tissue,
we determined the effect of SN50 treatment on Tcf promoter
activity in hBMSCs. SN50 decreased the promoter activities of
Top-Frash construct (Fig. 1B). To exclude nonspecific action of
SN50, we examined Tcf promoter activity in colon and breast
cancer cell lines in which β-catenin/Tcf signaling has been
Fig. 4. Effect of lzts2 downregulation on NF-κB and β-catenin/Tcf signals in hASCs. (A and B) lzts2 knock-down in hASCs. lzts2 expression in lzts2 siRNA or non-
target siRNA-transfected hASCs was determined by RT-PCR (A) and real-time PCR (B). (C) lzts2 siRNA or non-target siRNA-transfected hASCs were transfected
with NF-κB and Tcf reporter constructs vector. Luciferase activity was determined at 48 h after transfection and normalized by β-galactosidase activity. Data represent
mean±S.E.M. of four different experiments. ⁎pb0.05 compared with control oligo-transfected cells. (D) Western blot analysis of total, cytosolic and nuclear proteins
extracts obtained from lzts2 siRNA or non-target siRNA-transfected hASCs. One representative experiment from three independent experiments was shown.
Fig. 5. Effects of lzts2 downregulation on β-TrCP1 and IκBα expression in
hASCs. (A) β-TrCP1 expression of lzts2 siRNA or non-target siRNA-
transfected hASCs were determined by real-time PCR. Data represent mean±
S.E.M. of three different experiments. ⁎pb0.05 compared with control oligo-
transfected cells. (B) hASCs were transfected with lzts2 siRNA or non-target
siRNA for 72 h and then total proteins were immunoblotted with antibodies
against IκB-α and β-actin. One representative experiment from three
independent experiments was shown.
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(50 or 100 μg/ml) increased Tcf promoter activity in the COLO-
201 and SKBR-3 cell lines (Fig. 1C).
To further confirm the crosstalk between the NF-κB and β-
catenin/Tcf signaling pathways, we treated hASCs with mutant
and NF-κB decoy. The treatment with NF-κB decoy decreased
the luciferase activity of NF-κB and the Tcf promoter in
comparison to treatment with the mutant decoy (Fig. 2A). We
determined the effect of p65 overexpression on the activity of
the NF-κB and Tcf promoters. The overexpression of p65 in
hASCs by plasmid transfection increased the luciferase activity
of both the Tcf and NF-κB promoters (Fig. 2A).
To understand the mechanisms underlying the crosstalk
between the NF-κB and β-catenin/Tcf signaling pathways in
hASCs, the β-catenin levels in the total, nuclear and cytosolic
fractions were determined by Western blot analysis. The SN50
treatment inhibited the nuclear translocation of p65, as
expected. Although SN50 (100 μg/ml) treatment did not affect
the total β-catenin levels, it increased the β-catenin levels in the
cytosolic fractions and decreased the β-catenin levels in the
nuclear fractions of hASCs, indicating that SN50 inhibited
nuclear translocation of β-catenin as well as NF-κB (Fig. 2B).
A recent study showed that lzts2 is involved in the nuclear
translocation of β-catenin [33]. Therefore, we determined
whether of the expression of the lzts2 is regulated by NF-κB inhASC. Real-time PCR analysis showed that SN50 (100 μg/ml)
and NF-κB decoy increased lzts2 expression in hASCs. In
contrast, p65 overexpression by plasmid transfection decreased
lzts2 expression (Fig. 3A, B). To further confirm the role of
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oligo for downregulation of lzts2 expression. lzts2 siRNA-
transfected cells showed significant downregulation of the lzts2
gene in hASCs (about 80%) (Fig. 4A, B). We then determined
Tcf and NF-κB promoter activity in lzts2 siRNA-transfected
cells. The downregulation of lzts2 increased Tcf and NF-κB
promoter activity in the hASCs (Fig. 4C). To confirm thesefindings, Western blot analysis was used to determine the levels
of β-catenin and p65 in the hASCs. The downregulation of lzts2
expression increased the total and nuclear β-catenin levels, but
decreased the cytosolic β-catenin levels in the hASCs (Fig. 4D).
Although the downregulation of lzts2 expression did not affect
the total NF-κB levels in the hASCs, it did increase the nuclear
levels of p65 in these cells (Fig. 4D).
Fig. 6. Effect of lzts2 downregulation on changes in the proliferation and Tcf promoter activity of hASCs and hBMSCs by NF-κB inhibitors. (A) hASCs were transfected
with lzts2 siRNA or non-target control siRNA oligonucleotides. Identical number of siRNA-transfected hASCs (2000/cm2) was incubated for 42 and 72 h in the absence or
presence of mutant decoy, NF-κB decoy and SN50 (100 μg/ml). Proliferation of cells was determinedwith cell counting by a hemocytometer. Data represent mean±S.E.M.
of four different experiments. ⁎pb0.05 compared with control oligo-transfected cells. (C) Proliferation of lzts2 siRNA or non-target siRNA-transfected hASCs and hBMSC
in the absence or presence of SN50 (100 μg/ml) was determined on days 2 by MTT cell proliferation assay. Data represent mean±S.E.M. of four different experiments.
⁎pb0.05 compared with control oligo-transfected cells. (D) Cyclin D1 expression of lzts2 siRNA or non-target siRNA-transfected hASCs and hBMSC in the absence or
presence of SN50 (100 μg/ml) was determined by real-time PCR. Data represent mean±S.E.M. of three different experiments. ⁎pb0.05 compared with control oligo-
transfected cells. (E) Cell cycle of lzts2 siRNA or non-target siRNA-transfected hASCs and hBMSC in the absence or presence of SN50 (100μg/ml) was analyzed by FACS
2 days after transfection. (F andH) hASCs (F) and hBMSC (H) were transfected with lzts2 siRNA or non-target control siRNA oligonucleotides. siRNA-transfected hASCs
and hBMSC were cotransfected with Tcf reporter vector and β-Gal vector β-Gal vector 24 h after oligo transfection and incubated for 48 h in the presence or absence of
SN50 (100 μg/ml). Luciferase activity was normalized by β-galactosidase activity. Data represent mean±S.E.M. of four different experiments. ⁎pb0.05 compared with
control oligo-transfected cells. (B, G and I) Data in panels A, F andHwere transformed to the percentage of the changes in cell number (B) or Tcf promoter activity (G and I)
in the absence of NF-κB inhibitors to that in the presence of NF-κB inhibitors at 48 h after plating. Data represent mean±S.E.M. of four different experiments. ⁎pb0.05
compared with control oligo-transfected cells.
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induces NF-κB activation through the degradation of IκB, is
regulated by β-catenin/Tcf pathway [32]. Therefore, we
determined β-TrCP expression and IκB levels in lzts2 siRNA
oligo-transfected cells by real-time PCR and Western blot
analysis, respectively. Downregulation of lzts2 expression
increased the expression of β-TrCP1 and accompanied the
decreased of total IκB level in hASCs (Fig. 5A, B).
To examine whether NF-κB-induced effect on proliferation
and β-catenin/Tcf pathway is mediated by lzts2, we determined
whether lzts2 downregulation affected the NF-κB inhibitor-
induced decrease in the proliferation and Tcf promoter activity
of hASCs. Proliferation was determined by cell counting at 2
and 3 days after plating 20,000 hASCs. In control oligo-
transfected cells, SN50 (100 μg/ml) and NF-κB decoy
significantly inhibited proliferation of hASCs, and the down-regulation of lzts2 significantly increased it (Fig. 6A). In lzts2
siRNA oligo-transfected cells, the inhibition of cell proliferation
by SN50 and NF-κB decoy was greatly reduced (pb0.05) (Fig.
6B). To further confirm these effects, we performed MTT assay
and cell cycle analysis. MTT assay and cell cycle analysis
showed that the downregulation of lzts2 increased cell
proliferation and progression of cell cycle to S and G2/M
phase and the treatment of SN50 (100 μg/ml) inhibited them
(Fig. 6C, E). Cyclin D1, which is critical for entry into,
continuation of, and exit from the cell division cycle, is a
downstream target gene of Wnt signaling [34,35]. Real-time
PCR analysis of cyclin D1 expression showed that the treatment
of SN50 decreased cyclin D1 expression and lzts2 down-
regulation increased it in hASCs (Fig. 6D). Tcf promoter assay
revealed that lzts2 downregulation significantly reduced the
SN50-induced decrease in Tcf promoter activity in hASCs (Fig.
Fig. 7. lzts2 mediates crosstalk between NF-κB and β-catenin/Tcf pathways in
hASCs.
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on MTT assay, cell cycle progression, cyclin D1 expression and
Tcf promoter activity in hBMSCs showed identical effect with
hASCs (Fig. 6C–E, H, I).
4. Discussion
The results of our study showed that the inhibition of NF-κB
signaling pathway by SN50 or by NF-κB decoy oligonucleotides
inhibited the nuclear translocation of β-catenin or Tcf promoter
activity in hMSCs (Figs. 1, 2). Conversely, the overexpression of
p65 increased Tcf promoter activity in hASCs (Fig. 2). These
data clearly demonstrated that the inhibition or activation of NF-
κB signaling modulates β-catenin/Tcf pathway in hASCs with
direct correlationship.
Crosstalk between the β-catenin/Tcf and NF-κB signaling
pathways is mediated by their interactions at multiple cellular
levels. The data in the colon and breast cancer cell lines showed
that β-catenin is able to bind to NF-κB and reduce NF-κB DNA
binding [29]. The E3 ligase-mediated degradation of IκB leads
to the induction of NF-κB activity, and it also mediates the
degradation of β-catenin and inhibits the activity of the Wnt
pathway [36,37]. In addition, glycogen synthase kinase-3β
(GSK-3β) contributes to the degradation of β-catenin and
represses β-catenin/Tcf signaling, while the activity of NF-κB is
enhanced by GSK-3β [21,38]. However, these mechanisms do
not provide a complete explanation for the positive interaction
between β-catenin/Tcf and NF-κB pathways.
A recent study showed that lzts2 (leucine zipper tumor
suppressor 2), a putative tumor suppressor [33], interacts with
β-catenin, represses the transactivation of β-catenin, and affects
the subcellular localization of β-catenin. The data in this study
showed that the expression of lzts2 in hASCs was inversely
regulated by the activity of NF-κB. That is, overexpression of
the NF-κB subunit inhibited the expression of lzts2, whereas
treatment with NF-κB decoy or SN50 increased the expression
of lzts2 (Fig. 3). NF-κB-induced downregulation of lzts2
expression also provided the explanation about SN50-induced
decrease of nuclear translocation of β-catenin.
The findings that the downregulation of lzts2 by RNA
interference increased NF-κB activity, upregulated the levels of
β-catenin, and increased the translocation of β-catenin into
nucleus and Tcf promoter activity indicated reciprocal interac-
tion between NF-κB and β-catenin/Tcf pathways (Fig. 4).
We previously reported that endogenous canonical Wnt
signaling increased proliferation of hASCs [22]. Stimulatory
effect of lzts2 downregulation on cell proliferation in hASCs
in this study further supports the role of canonical pathway
on the proliferation of hASCs. The data in this study
showed that the inhibition of NF-κB activity inhibited the
proliferation of hASCs, which can be mediated by a direct or β-
catenin-dependent action of NF-κB pathway (Fig. 6). Because
the inhibitory effect of NF-κB inhibitors on cell proliferation
was blocked by the downregulation of lzts2 in this study, NF-
κB-induced increase of β-catenin transactivation rather than its
direct action plays a major role on NF-κB-mediated proliferation
of hASCs (Fig. 6). The findings in this study that lzts2downregulation block the effect of SN50 or NF-κB decoy on
Tcf promoter activity also supported the lzts2 dependency of
NF-κB-mediated modulation of β-catenin/Tcf pathways in
hASCs. The lzts2-mediated crossregulation between NF-κB
and β-catenin/Tcf pathways is not specific in hASCs, because
the treatment of SN50 and the downregulation of lzts2 in
hBMSCs showed the identical effects with those of hASCs
(Fig. 6C–E, H, I).It has been known that the transactivation of
Tcf/Lef results in the upregulation of the E3 ligase β-TrCPs [32].
β-TrCP recognizes identical phosphorylated motifs on β-
catenin and IκB and binds to these phosphorylated proteins,
resulting in the tethering of the ubiquitin ligase machinery and
subsequent degradation of IκB by the 26S proteasome in colon
epithelial cells, 293 cells and smooth muscle cells [37,39,40].
However, activation of the β-catenin/Tcf pathway had no effect
on β-TrCP1 expression in fibroblasts [40]. Our data in this study
showed that lzts2-siRNA-transfected hASCs showed higher
expression of β-TrCP1 and lower IκB levels in hASCs than
control oligo-treated cells. These findings indicate that lzts2
downregulation-induced activation of β-catenin/Tcf pathway
increases β-TrCP1 expression and induces subsequently the
degradation of IκB and activation of NF-κB pathway. The
increased total β-catenin levels in silzts2-transfected hASCs in
spite of its β-TrCP-induced degradation can be explained by the
counterbalance of β-catenin level resulted from the lzts2
downregulation-induced increased β-catenin.
It has been reported that Wnt signaling regulates adipogenic
differentiation of MSCs [41], and TNF-alpha, an activator of
NF-κB pathway, inhibits adipogenesis via a β-catenin/TCF4
(TCF7L2)-dependent pathway [42]. These results suggest that
the interaction between NF-κB and β-catenin/Tcf pathways
plays some roles in the regulation of MSCs differentiation as
well as proliferation.
A schematic diagram in Fig. 7 illustrates our current un-
derstanding of the reciprocal interaction between the Wnt and
NF-κB signaling pathways in hMSCs. Activation of NF-κB
decreases lzts2 expression. The decrease of lzts2 level
increases nuclear translocation of β-catenin and transactiva-
tion of Tcf/Lef. Transactivation of Tcf/Lef results in the
427H.H. Cho et. al. / Biochimica et Biophysica Acta 1783 (2008) 419–428upregulation of β-TrCP1. β-TrCP1 recognizes identical
phosphorylated motifs on IκB and results in the degradation
of IκB by the 26S proteosome and NF-κB activation. The
novel finding in this study is that the positive interaction
between NF-κB activity and β-catenin/Tcf pathway involves
the regulation of proliferation of hMSCs, and that their
interaction is mediated by lzts2 expression.
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